Literature DB >> 25878337

Discrimination of Candida albicans from Candida dubliniensis by Use of the BioFire FilmArray Blood Culture Identification Panel.

Timothy R Southern1, Aqilah Alelew2, Peter C Iwen3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25878337      PMCID： PMC4432046          DOI： 10.1128/JCM.00299-15

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  9 in total

1.  Use of a panfungal PCR assay for detection of fungal pathogens in a commercial blood culture system.

Authors:  Peter C Iwen; Alison G Freifeld; Tricia A Bruening; Steven H Hinrichs
Journal:  J Clin Microbiol       Date:  2004-05       Impact factor: 5.948

2.  Septic shock attributed to Candida infection: importance of empiric therapy and source control.

Authors:  Marin Kollef; Scott Micek; Nicholas Hampton; Joshua A Doherty; Anand Kumar
Journal:  Clin Infect Dis       Date:  2012-03-15       Impact factor: 9.079

Review 3.  Candida dubliniensis: epidemiology and phenotypic methods for identification.

Authors:  Erico Silva Loreto; Liliane A Scheid; Cristina W Nogueira; Gilson Zeni; Janio M Santurio; Sydney H Alves
Journal:  Mycopathologia       Date:  2010-02-21       Impact factor: 2.574

Review 4.  Relative frequency of albicans and the various non-albicans Candida spp among candidemia isolates from inpatients in various parts of the world: a systematic review.

Authors:  Matthew E Falagas; Nikos Roussos; Konstantinos Z Vardakas
Journal:  Int J Infect Dis       Date:  2010-08-24       Impact factor: 3.623

5.  Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidosis in HIV-infected individuals.

Authors:  D J Sullivan; T J Westerneng; K A Haynes; D E Bennett; D C Coleman
Journal:  Microbiology       Date:  1995-07       Impact factor: 2.777

Review 6.  Candida albicans or Candida dubliniensis?

Authors:  Ruan Ells; Johan L F Kock; Carolina H Pohl
Journal:  Mycoses       Date:  2011-01       Impact factor: 4.377

7.  Significance of molecular identification and antifungal susceptibility of clinically significant yeasts and moulds in a global antifungal surveillance programme.

Authors:  Michael A Pfaller; Leah N Woosley; Shawn A Messer; Ronald N Jones; Mariana Castanheira
Journal:  Mycopathologia       Date:  2012-05-13       Impact factor: 2.574

8.  Candida dubliniensis: an appraisal of its clinical significance as a bloodstream pathogen.

Authors:  Ziauddin Khan; Suhail Ahmad; Leena Joseph; Rachel Chandy
Journal:  PLoS One       Date:  2012-03-02       Impact factor: 3.240

Review 9.  Invasive candidiasis as a cause of sepsis in the critically ill patient.

Authors:  Julie Delaloye; Thierry Calandra
Journal:  Virulence       Date:  2013-08-27       Impact factor: 5.882
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.